questionText: To ask the Secretary of State for Health and Social Care, what discussions he has had with NHS England, the National Institute for Health and Care Excellence and the Medicines and Healthcare products Regulatory Agency on the annual meeting held to discuss progress and the role of the Early Access to Medicines Scheme, the Innovative Licensing and Access Pathway and the Innovative Medicines Fund in supporting access to treatments for people living with rare diseases.
answerText: The Government is committed to improving the lives of people living with rare diseases through the UK Rare Diseases Framework. One of the priorities of the framework is improving access to specialist care, treatment, and drugs.We have continued to review ...
heading: Rare Diseases: Medical Treatments